Mitochondrial Disease in Childhood: MtDNA Encoded

Neurotherapeutics

Volumn 10, Issue 2, 2013, Pages 199-211

  Saneto, Russell P ^a   Sedensky, Margret M ^b  

^a SEATTLE CHILDREN S HOSPITAL   (United States)

^b SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

Genetic diseases; Maternal inheritance; Mitochondrial DNA; Mitochondrial physiology; Oxidative phosphorylation

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CYTOCHROME C OXIDASE; FLAVINE ADENINE NUCLEOTIDE; MITOCHONDRIAL DNA; MITOCHONDRIAL TRANSCRIPTION FACTOR B; THIOCTIC ACID; UBIDECARENONE;

BOTTLENECK POPULATION; CELL DIVISION; CELL EXPANSION; CELL FUNCTION; CELL STRUCTURE; CHILDHOOD DISEASE; CLONING; CYTOCHROME C OXIDASE DEFICIENCY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA CONTENT; ELECTRON TRANSPORT; ENDURANCE TRAINING; EPIDEMIOLOGY; EXTRACHROMOSOMAL INHERITANCE; FATTY ACID OXIDATION; GENE DELETION; GENE REARRANGEMENT; GENETICS; HETEROPLASMY; HUMAN; INFANCY; KEARNS SAYRE SYNDROME; KINESIOTHERAPY; LEBER HEREDITARY OPTIC NEUROPATHY; LEIGH DISEASE; MELAS SYNDROME; MERRF SYNDROME; MITOCHONDRIAL GENETICS; NARP SYNDROME; NEWBORN DISEASE; OOCYTE MATURATION; OXIDATIVE PHOSPHORYLATION; PEARSON SYNDROME; POINT MUTATION; PREVALENCE; PRIORITY JOURNAL; REVIEW;

EID: 84876186368     PISSN: 19337213     EISSN: 18787479     Source Type: Journal    
DOI: 10.1007/s13311-012-0167-0     Document Type: Review

References (123)

1. Chinnery PF, Johnson MA, Wardell TM, et al. The epidemiology of pathogenic mitochondrial DNA mutations. Ann Neurol 2000; 48: 188-193.
2. Skladal D, Halliday J, Thorburn DR. Minimum birth prevalence of mitochondrial respiratory chain disorders in children. Brain 2003; 126: 1905-1912.
3. Benard G, Rossignol R. Ultrastructure of the mitochondrion and its bearing on function and bioenergetics. Antioxid Redox Signal 2008; 10: 1313-1342.
4. Milone M, Benarroch EE. Mitochondrial dynamics: General concepts and clinical implications. Neurology 2012; 78: 1612-1619.
5. Saraste, M. Oxidative phosphorylation at the fin de siecle. Science 1999; 283: 579-587.
6. Nouws J, Nijtmans LGJ, Smeitink JA, Vogel RO. Assembly factors as a new class of disease genes for mitochondrial complex I deficiency: cause pathology and treatment options. Brain 2012; 135: 12-22.
7. Anderson S, Bankier AT, Barrell BG, et al. Sequence and organization of the human mitochondrial genome. Nature 1981; 290: 457-465.
8. Di Re M, Sembngi H, He J, et al. The accessory subunit of mitochondrial DNA polymerase gamma determines the DNA content of mitochondrial nucleoids in human cultured cells. Nucleic Acids Res 2009; 37: 5701-5713.
9. Holt IJ, He J, Mao CC, et al. Mammalian mitochondrial nucleoids: Organizing an independently minded genome. Mitochondrion 2007; 7: 311-321.
10. Wang Y, Bogenhagen DF. Human mitochondrial DNA nucleoids are linked to protein folding machinery and metabolic enzymes at the mitochondrial inner membrane. J Biol Chem 2006; 281: 25791-25802.
11. Iborra FJ,. Kimura H, Cook PR. The functional organization of mitochondrial genomes in human cells. BMC Biol 2004; 2: 9.
12. Bogenhagen D, Clayton DA. Mouse L cell mitochondrial DNA molecules are selected randomly for replication throughout the cell cycle. Cell 1977; 11: 719-727.
13. Taanman JW, Muddle JR, Muntau AC. Mitochondrial DNA depletion can be prevented by cGMP and dAMP supplementation in a resting culture of deoxyguanosine kinase-deficient fibroblasts. Hum Mol Genet 2003; 12: 1839-1845.
14. Graziewicz MA, Longley MJ, Copeland WC. DNA polymerase gamma in mitochondrial DNA replication and repair. Chem Rev 2006; 106: 383-405.
15. Carrodeguass JA, Theis K, Bogenhagen DF, Kisker C. Crystal structure and deletion analysis show that the accessory subunit of mammalian DNA polymerase gamma, Pol gamma B, functions as a homodimer. Mol Cell 2001; 7: 43-54.
16. Spelbrink JN, Tolvonen JM, Hakkaart GA, et al. In vivo functional analysis of the human mitochondrial DNA polymerase POLG expressed in cultured human cells. J Biol Chem 2000; 275: 24818-24828.
17. Copeland WC. Inherited mitochondrial diseases of DNA replication. Ann Rev Med 2008; 59: 131-146.
18. Clayton DA. Replication of animal mitochondrial DNA. Cell 1982; 28: 693-705.
19. Yasukawa T, Reyes A, Cluett TJ, et al. Replication of vertebrate mitochondrial DNA entails transient ribonucleotide incorporation throughout the lagging strand. EMBO J 2006; 25: 5358-5371.
20. Holt IJ. Mitochondrial DNA replication and repair: all a flap. Trends Biochem Sci 2009; 34: 358-365.
21. Ojala D, Montoya J, Attardi G. tRNA punctuation model of RNA processing in human mitochondria. Nature 1981; 290: 470-474.
22. Clayton DA. Replication and transcription of vertebrate mitochondrial DNA. Annu Rev Cell Biol 1991: 453-478.
23. Scarpulla RC. Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol Rev 2008; 88: 611-638.
24. Falkenberg M, Larsson NG, Gustafsson CM. DNA replication and transcription in mammalian mitochondria. Ann Rev Biochem 2007; 76: 679-699.
25. O'Brien TW. Properties of human mitochondrial ribosomes. IUBMB 2003; 55: 505-513.
26. Nagaike T, Suzuki T, Ureda. Polyadenylation in mammalian mitochondria; insights from recent studies. Biochim Biophys Acta 2008; 1779: 266-269.
27. Anderson S, de Brujn MH, Coulson AR, Eperon IC, Sanger F, Young IG. Complete sequence of bovine mitochondrial DNA. Conserved features of the mammalian mitochondrial genome. J Mol Biol 1982; 156: 683-717.
28. Sengupta S, Yang X, Higgs PG. The mechanisms of codon reassignments in mitochondrial genetic codes. J Mol Evol 2007; 64: 662-688.
29. Holt IJ, Harding AE, Morgan-Hughes JA. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 1988; 331: 717-719.
30. Wallace DC, Singh G, Lott MT, et al. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 1988; 242: 1427-1430.
31. MITOMAP: A Human Mitochondrial Genome Database: Available at: http://www. mitomap. org. Accessed August 1, 2012.
32. Rossignol R, Faustin B, Rocher C, Malgat M, Mazat JP, Letellier T. Mitochondrial threshold effects. Biochem J 2003; 370: 751-762.
33. Sacconi S, Salviati L, Nishigaki Y, et al. A functionally dominant mitochondrial DNA mutation. Hum Mol Genet 2008; 17: 1814-1820.
34. Giles RE, Blanc H, Cann HM, Wallace DC. Maternal inheritance of human mitochondrial DNA. Proc Natl Acad Sci 1980; 77: 6715-6719.
35. Sato M, Sato K. Degradation of paternal mitochondria by fertilization-triggered autophagy in C. elegans embryos. Science 2011; 334: 1141-1144.
36. Al Rawi S, Louvet-Vallee S, Djeddi A, et al. Postfertilization autophagy of sperm organelles prevents paternal mitochondrial DNA transmission. Science 2011; 334: 1144-1147.
37. Schwartz M, Vissing J. Paternal inheritance of mitochondrial DNA. New Engl J Med 2002; 347: 576-580.
38. Schwartz M, Vissing J. No evidence for paternal inheritance of mtDNA in patients with sporadic mtDNA mutations. J Neurol Sci 2004; 218: 99-101.
39. Filosto M, Mancuso M, Vives-Bauza C, et al. Lack of paternal inheritance of muscle mitochondrial DNA in sporadic mitochondrial myopathies. Ann Neurol 2003; 54: 524-526.
40. Taylor RW, McDonnell MT, Blakely EL, et al. Genotypes from patients indicates no paternal mitochondrial DNA contribution. Ann Neurol 2003; 54: 521-524.
41. Hauswirth WW, Paipis PJ. Mitochondrial DNA polymorphism in a maternal lineage of Holstein cows. Proc Natl Acad Sci U S A 1982; 79: 4686-4690.
42. Carling PJ, Cree LM, Chinnery PF. The implications of mitochondrial DNA copy number regulation during embryogenesis. Mitochondrion 2011; 11: 686-692.
43. Piko I, Matsummoto L. Number of mitochondria and some properties of mitochondrial DNA in the mouse egg. Dev Biol 1976; 49: 1-10.
44. Cao L, Shitara H, Sugimoto M, Hayashi J-I, Abe K, Yonekawa H. New evidence confirms that mitochondrial bottleneck is generated without reduction of mitochondrial DNA content in early primordial germ cells of mice. PLoS Genet 2009; 5: e1000756. doi: 10. 1371/journal. pgen. 1000756.
45. Jenuth FP, Peterson AC, Fu K, Shoubridge EA. Random genetic drift in the female germline explains the rapid segregation of mammalian mitochondrial DNA. Nat Genet 1996; 14: 146-151.
46. Wai T, Teoli D, Shoubridge EA. The mitochondrial DNA genetic bottleneck results from replication of a subpopulation of genomes. Nat Genet 2008; 40: 1484-1488.
47. Rahman S, Poulton J, Marchington D, Suomalainen A. Decrease of 3243 A & G mtDNA mutation from blood in MELAS syndrome: a longitudinal study. Am J Hum genet 2001; 68: 238-240.
48. Schaefer AM, Taylor RW, Turnbull DM, Chinnery PF. The epidemiology of mitochondrial disorders-past, present and future. Biochim Biophys Acta 2004; 1659: 115-120.
49. Smeitink JA, Zeviani M, Turnbull DM, Jackobs HT. Mitochondrial medicine: a metabolic perspective on the pathology of oxidative phosphorylation disorders. Cell Metab 2006; 3: 1-13.
50. Elliott HR, Samuels DC, Eden JA, Reltoin CL, Chinnery PF. Pathogenic mitochondrial DNA mutations are common in the general population. Am J Hum Genet 2008; 83: 254-260.
51. Schaefer AM, McFarland R, Blakely EL, et al. Prevalence of mitochondrial DNA disease in adults. Ann Neurol 2008; 63: 35-39.
52. Darin N, Oldfors A, Moslemi Ar, Holme E, Tulinius M. The incidence of mitochondrial encephalomyopathies in childhood: clinical features and morphological, biochemical and DNA abnormalities. Ann Neurol 2001; 49: 377-383.
53. Ferrari G, Lamantea E, Donati A, et al. Infantile hepatocerebral syndromes associated with mutations in the mitochondrial DNA-polymerase-γ A. Brain 2005; 128: 723-731.
54. Debray F-G, Lambert M, Chevalier I, et al. Long-term outcome and clinical spectrum of 73 patients with mitochondrial disease. Pediatrics 2007; 119: 722-733.
55. Gibson K, Halliday JL, Kirby DM, Yaplito-Lee J, Thorburn DR. Mitochondrial oxidative phosphorylation disorders presenting in neonates: clinical manifestations and enzymatic and molecular diagnosis. Pediatrics 2008; 122: 1003-1008.
56. Rubio-Gozalbo ME, Dijkman KP, van den Heuvel LP, Sengers RC, Wendel U, Smeitink JA. Clinical differences in patients with mitochondriocytopathies due to nuclear versus mitochondrial DNA mutations. Hum Mutat 2000; 15: 522-532.
57. Sue CM, Bruno C, Andreu AL, et al. Infantile encephalopathy associated with the MELAS A3243G mutation. J Pediatr 1999; 134: 696-700.
58. McFarland R, Clark AA, Morris AA, et al. Multiple neonatal deaths due to a homoplasmic mitochondrial DNA mutation. Nat Genet 2002; 30: 145-146.
59. Taylor RW, Giordano C, Davidson MM, et al. A homplasmic mitochondrial transfer ribonucleic acid mutation as a cause of maternally inherited hypertrophic cardiomyopathy. J Am Coll Cardiol 2003; 41: 1786-1796.
60. McFarland R, Schaefer AM, Gardner JL, et al. Familial myopathy: new insights into the T14709C mitochondrial tRNA mutation. Ann Neurol 2004; 55: 478-484.
61. Horvath R, Kemp JP, Tuppen HA, et al. Molecular basis of infantile reversible cytochrome c oxidase deficiency myopathy. Brain 2009; 132: 3165-3174.
62. Mitchell AL, Elson JL, Howell N, Taylor RW, Turnbull DM. Sequence variation in mitochondrial complex I genes; mutation or polymorphism? J Med Genet 2006; 43: 175-179.
63. Swalwell H, Blakely EL, Sutton R, et al. A homoplasmic mtDNA variant can influence the phenotype of the pathogenic m7472CinsMTTSI mutation: are two mutations better than one? Eur J Hum Genet 2008; 16: 1265-1274.
64. Cai W, Fu Q, Zhou X, Qu J, Tong Y, Guan MX. Mitochondrial variants may influence the phenotype manifestation of Leber's hereditary optic neuropathy-associated ND4 G11778A mutation. J Genet Genomics 2008; 35: 649-655.
65. Schon EA, Rizzuto R, Moraes CT, Nakase H, Zeviani M, DiMauro S. A direct repeat is a hotspot for large-scale deletion of human mitochondrial DNA. Science 1989; 144: 346-349.
66. Sadikovic B, Wang J, El-Hattab A, et al. Sequence homology at the breakpoint and clinical phenotype of mitochondrial DNA deletion syndromes. PLoS One 2010; 5: e15687. doi: 101371/journal. pone. 0015687.
67. Chen X, Prosser R, Simonetti S, Sadlock J, Jagiello G, Schon EA. Rearranged mitochondrial genomes are present in human oocytes. Am J Hum Genet 1995; 57: 239-247.
68. Shoffner FM, Lott MT, Voljavec AS, Soueidan SA, Costigan DA, Wallace DC. Spontaneous Kearns-Sayre/chronic external ophthalmoplegia plus syndrome associated with mitochondrial DNA deletion: a slip-replication model and metabolic therapy. Proc Natl Acad Sci U S A, 1989; 86: 7952-7956.
69. Krishnan KJ, Reeve AK, Samuels DC, et al. What causes mitochondrial DNA deletions in human cells? Nat Genet 2008; 40: 275-279.
70. Dunbar DR, Moonie PA, Swingler RJ, Davidson D, Roberts R, Holt IJ. Maternally transmitted partial direct tandem duplication of mitochondrial DNA associated with diabetes mellitus. Hum Molec Genet 1993; 2: 1619-1624.
71. Saneto RP, Naviaux RK. Polymerase gamma disease through the ages. Dev Disabil Res Rev 2010; 16: 163-174.
72. Spinazzola A, Zeviani M. Disorders of nuclear-mitochondrial intergenomic signaling. Gene 2005; 354: 162-168.
73. Koopman WJH, Willems PHGM, Smeitink JAM. Mongenic mitochondrial disorders. N Engl J Med 2012; 366: 1132-1141.
74. Garcia-Cazorla A, De Lonlay P, Nossogne MC, Rustin P, Touati G, Saudubray JM. Long-term follow-up of neonatal mitochondrial cytopathies: a study of 57 patients. Pediatrics 2005; 116: 1170-1177.
75. Papa S. Mitochondrial oxidative phosphorylation changes in the life span. Molecular aspects and physiopathological implications. Bichem Biophys Acta 1996; 1276: 87-105.
76. McFarland R, Clark KM, Morris AA, et al. Multiple neonatal deaths due to homoplasmic mitochondrial DNA mutation. Hum Genet 2002; 30: 145-146.
77. Finsterer J. Leigh and Leigh-like syndrome in children and adults. Pediatric Neurology 2008; 39: 223-235.
78. Leigh D. Subacute necrotizing encephalomyelopathy in an infant. J Neurol Neurosurg Psych 1951; 14: 216-221.
79. Saneto RP, Friedman SD, Shaw DWW. Neuroimaging of mitochondrial disease. Mitochondrion 2008; 8: 396-413.
80. Ostergaard E, Hansen FJ, Sorensen N, et al. Mitochondrial encephalomyopathy with elevated methylmalonic acid is caused by SUCLA2 mutations. Brain 2007; 130: 853-861.
81. Piao YS, Tang GC, Yand H, Lu DH. Clinico-neuropathological study of a Chinese case of familial adult Leigh syndrome. Neuropathology 2006; 26: 218-221.
82. Bugiani M, Tiranti V, Farina L, Uziel G, Zeviani M. Novel mutations in COX15 in a long surviving Leigh syndrome patient with cytochrome c oxidase deficiency. J Med Genet 2005: 42: e28.
83. Martin E, Burger R, Wiestler OD, Caduff R, Boltshauser E, Boesch C. Brainstem lesion revealed by MRI in a case of Leigh's disease with respiratory failure. Ped Radiol 1990; 20: 349-350.
84. Rahman S, Blok RB, Dahl HHM, et al. Leigh syndrome: clinical features and biochemical and DNA abnormalities. Ann Neurol 1996; 39: 343-351.
85. Pearson HA, Lobel JS, Kocoshis SA, et al. A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction. J Pediat 1979; 95: 976-984.
86. Rotig A, Cormier V, Blanche S, et al. Pearson's marrow-pancrease syndrome: a multisystem mitochondrial disorder in infancy. J Clin Invest 1990; 86: 1601-1608.
87. Moraes CT, DiMauro S, Zeviani M, et al. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N Engl J Med 1989; 320: 1293-1299.
88. DiMauro S, Nicholson JF, Hays AP, Eastwood AB, Koenigsberger R, DeVivo DC. Benign infantile mitochondrial myopathy due to reversible cytochrome c oxidase activity. Trans Am Neurol Assoc 1981; 106: 205-207.
89. Horvath R, Kemp JP, Tuppen HAL, et al. Molecular basis of infantile reversible cytochrome c oxidase deficiency myopathy. Brain 2009; 132: 3165-3174.
90. Silvestri G, Santorelli FM, Shanske S, et al. A new mtDNA mutation in the tRNA (Leu(UUR)) gene associated with maternally inherited cardiomyopathy. Hum Mut 1994; 3: 37-43.
91. Skladal D, Sudmeier C, Konstantopoulou V, et al. The clinical spectrum of mitochondrial disease in 75 pediatric patients. Clin Pediatr 2001; 42: 703-710.
92. Scaglia F, Towgin JA, Craigen WJ, et al. Clinical spectrum, morbidity, and mortality in 113 pediatric patients with mitochondrial disease. Pediatrics 2004; 114: 925-931.
93. Hirano M, Pavlakis SG. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): current concepts. J Child Neurol 1994; 9: 4-13.
94. Ribacoba R, Salas-Puig J, Gonzalez C, Astudillo A. Characteristics of status epilepticus in MELAS. Analysis of four cases. Neurology 2006; 21: 1-11.
95. Saneto RP, Bouldin A. A boy with muscle weakness, hypercarbia, and the mitochondrial DNA A3243G mutation. J Child Neurol 2006; 21: 77-79.
96. Groto Y, Nonaka I, Horai S. A mutation in tRNALeu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalopathies. Nature 1990; 348: 651-653.
97. Groto Y, Nonaka I, Horai S. A new mtDNA mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS). Biochim Biophys Acta 1991; 1097: 238-240.
98. Taylor RW, Chinnery PF, Haldane F, et al. MELAS associated with a mutation in the valine transfer RNA gene of mitochondrial DNA. Ann Neurol 1996; 40: 459-462.
99. Shanske S, Coku J, Lu J, et al. The G13513A mutation in the ND5 gene of mitochondrial DNA as a common cause of MELAS or Leigh syndrome: evidence from 12 cases. Arch Neurol 2008; 65: 368-372.
100. Liolitsa D, Rahman S, Benton S, Carr LJ, Hanna MG. Is the mitochondrial complex I ND5 gene a hot-spot for MELAS causing mutations? Ann Neurol 2003; 53: 128-132.
101. Manfredi G, Schon EA, Moraes CT, et al. A new mutation associated with MELAS is located in a mitochondrial DNA polypeptide-coding gene. Neuromuscul Disord 1995; 5: 391-398.
102. Maceluch JA, Niedziela M. The clinical diagnosis and molecular genetics of Kearns-Sayre syndrome: a complex mitochondrial encephalomyopathy. Pediatr Endocrinol Rev 2006; 4: 117-137.
103. Holt IJ, Harding AE, Petty RK, Morgan-Hughes JA. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet 1990; 46: 428-433.
104. Sembrano E, Barthlen GM, Wallace S, Lamm C. Polysomnographic findings in a patient with the mitochondrial encephalomyopathy NARP. Neurology 1997; 49: 1714-1717.
105. Santorelli FM, Tanji K, Shanske S, DiMauro S. Heterogeneous clinical presentation of the mtDNA NARP/T8993G mutation. Neurology 1997; 49: 270-273.
106. Wong L-JC. Pathogeneic mitochondrial DNA mutations in protein-coding genes. Muscle Nerve 2007; 36: 279-293.
107. Riordan-Eva P, Sanders MD, Govan GG, Sweeney MG, Da Costa J, Harding AE. The clinical features of Leber's hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation. Brain 1995; 118: 319-337.
108. th ed. Vol II. McGraw-Hill, New York, 2001, pp. 2425-2509.
109. Carelli V, Achilli A, Valentino ML, et al. Haplogroup effects and recombination of mitochondrial DNA: novel clues from the analysis of Leber hereditary optic neuropathy pedigrees. Am J Hum Genet 2006; 78: 564-574.
110. Kirkman MA, Yu-Wai-Man P, Korsten A, et al. Gene-environment interactions in Leber hereditary optic neuropathy. Brain 2009; 132: 2317-2326.
111. Giordano C, Monopoli M, Perli E, et al. Oestrogens ameliorate mitochondrial dysfunction in Leber's hereditary optic neuropathy. Brain 2011; 134: 220-234.
112. Hirano M, DiMauro S. Clinical features of mitochondrial myopathies and encephalomyopathies. In: Lane RJM (ed.), Handbook of Muscle Disease, Vol 1. Marcel Dekker Inc., New York, pp. 479-504.
113. Shoffner JM, Lott MT, Lezza AM, Seibel P, Ballinger SW, Wallace DC. Myoclonic epilepsy and ragged-red fibers (MERRF) is associated with mitochondrial DNA tRNA(lys) mutation. Cell 1990; 61: 931-937.
114. Yoneda M, Tanno Y, Horai S, Ozawa T, Miyatake T, Tsuji S. A common mitochondrial mutation DNA mutation in the tRNA(Lys) of patients with myoclonus epilepsy associated with ragged-red fibers. Biochem Int 1990; 21: 789-796.
115. DiMauro S, Hirano M. MERRF. In: Pagon RA, Bird TD, Dolan CR et al. (eds) GeneReviews [Internet]. University of Washington, Seattle, WA, 1993. Available at: http//www. ncbi. nlm. nih. gov/books/NDB1520.
116. Haas RH, Parikh S, Falk MJ, et al. Mitochondrial disease: a practical approach for primary care physicians. Pediatrics 2007; 120: 1326-1333.
117. Hass RH, Parikh S, Falk JM, et al. The in-depth evaluation of suspected mitochondrial disease. Mol Genet and Metab 2008; 94: 16-37.
118. Frederiksen AL, Andersen PH, Kyvik KO, Jeppesen TD, Vissing J, Schwartz M. Tissue specific distribution of the 3243A- & G mtDNA mutation. J Med Genet 2006; 43: 671-677.
119. de Laat P, Koene S, van den Heuvel LPWJ, Rodenburg RJT, Jensen MCH, Smeitink JAM. Clinical features and heteroplasmy in blood, urine and saliva in 34 Dutch families carrying the m. 3243A: G mutation. J Inherit Metab Dis 2012 Mar 9 (Epub ahead of print).
120. Pfeffer G, Majamaa K, Turnbull DM, Thorburn D, Chinnery PF. Treatment for mitochondrial disorders. Cochrane Database Syst Rev 2012; 4: CD004426.
121. Enns GM, Kinsman SL, Perlman SL, et al. Initial experience in the treatment of inherited mitochondrial disease with EPI-743. Mol Genet Metab 2012; 105: 91-102.
122. Taivassalo T, Gardner JL, Taylor RW, et al. Endurance training and detraining in mitochondrial myopathies due to single large-scale mtDNA deletions. Brain 2006; 129: 3391-3401.
123. Taivassalo T, Haller RG. Exercise and training in mitochondrial myopathies. Med Sci Sports Exerc 2005; 37: 2094-2101.